Haemonetics Corp. (HAE) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $107.60 --0%
Revenue Growth %: +5.5%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.5%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral
- Needham Reiterates Hold Rating on Envista Holdings Corp. (NVST)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
